The NHS cannot meet the “tidal wave” of demand for weight-loss jabs, medics say. A report calling for a review of existing ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Mintel, the experts in what consumers want and why, has today announced four key trends that will shape the global food and drink industry in the years ahead. In 2025 and beyond, expect to see GLP-1 ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

ROACH: I am 5 feet, 1 inch tall, weigh 200 pounds, and have found it next to impossible to lose weight, even though I'm active. I swim, walk, or do yoga almost every day. I avoid most processed foods ...

New York rap icon Fat Joe recently opened up about his battle with diabetes and his use of Ozempic as part of his broader weight loss journey. Before you start the judgement, Fat Joe, has been ...

Support for people living with obesity is “insufficient”, experts have said after a new report revealed that some patients are being asked to wait for up to five years for specialist support. Some ...

A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss jabs could be given to unemployed people to help them return to the workplace.

A global survey of breast cancer patients reveals a gap in support services for managing the mental and physical side effects experienced by those undergoing treatment.

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...